Oct 20, 2009
The VerteLoc™ Minimally Invasive Spine Stabilization system surpasses 750 surgical procedures across the United States. VGI will unveil its new VerteLX™ prototypes at the upcoming Congress of Neurological Surgeons meeting in New Orleans, October 26 – 28.
Winston-Salem, NC (PRWEB), October 20, 2009 — VG Innovations, Inc (VGI), announced today that its VerteLoc™ Minimally Invasive Spine Stabilization system has now been utilized in more than 750 procedures.
“Our VerteLoc™, system continues to grow in popularity with forward-thinking surgeons” stated VGI’s President and CEO, Dan Grayson. “It is making a significant difference in the way back pain is being addressed, serving to add a new option for patients and surgeons in the continuum of spine care.”
“The growth of VGI in just 15 months is nothing short of phenomenal,” Grayson continued. “However, we are ready to take the next step in elevating our company to the next level with the introduction of a unique lateral access interbody fusion system, VerteLX™. We still have a long way to go before our scheduled launch in 2010, but I think surgeons will react favorably to our creative engineering and thinking when the prototypes are unveiled at the Congress of Neurological Surgeons meeting next week in New Orleans. I encourage surgeons who are interested in seeing the VerteLX™ system to visit us at Booth 343.”
VerteLX™ is a new concept for intravertebral fusion, as it is inserted through a minimally invasive lateral approach, to minimize tissue damage and recovery time of the patient,” exclaimed Tov Vestgaarden, PhD, Executive VP and CTO of VGI. “The unique cannula allows for ease of distraction of the joint, while at the same time guides the instruments to complete the procedure quickly and with precision. Unlike current intravertebral spacers, VerteLX™ will provide multi-directional stability. We also see an application for this technology in the cervical spine.”
Company Profile
VG Innovations, Inc, (VGI) is a privately held company and was formed in late 2007. The company is in the business of developing and commercializing proprietary, implantable devices with a specific focus on minimally invasive surgical products that could provide better surgical solutions over present technology. The products are designed to treat specific spinal disease indications that affect millions of people. More information on the company and its products can be found at: http://www.verteloc.com